Kinnate Biopharma Inc (KNTE) insider trading

Every open-market stock purchase and sale by Kinnate Biopharma Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

No open-market insider trades in the last 12 months.
Last insider buy: Foresite Capital Management IV LLC (10% owner), $4.3M, 3 years ago.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).

Recent KNTE insider trades

No open-market trades in the last 12 months.

Get free alerts when an insider at Kinnate Biopharma Inc files a new trade →